25/03/2022
Rheumatoid Arthritis: is indicated for the treatment of adult patients with moderately to severely active who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).
Psoriatic Arthritis: Tofacitinib is indicated for the of adult patients with active who have had an inadequate response or intolerance to methotrexate or other disease-modifying drugs (DMARDs).
Ulcerative Colitis: Tofacitinib is indicated for the treatment of with moderately to severely active (UC).